Human serum paraoxonase
- PMID: 9703197
- DOI: 10.1016/s0306-3623(98)00028-7
Human serum paraoxonase
Abstract
1. Human serum paraoxonase (PON1) is a Ca2+-dependent 45-kDa glycoprotein that is associated with high density lipoprotein (HDL). 2. PON1 hydrolyzes organophosphate (OP) insecticides and nerve gases and is responsible for determining the selective toxicity of these compounds in mammals. 3. PON1 has two genetic polymorphisms giving rise to amino acid substitutions at positions 55 and 192. The position-192 polymorphism is the major determinant of the PON1 activity polymorphism. However, the position-55 polymorphism also modulates activity. 4. Genotyping individuals for both PON1 polymorphisms may provide a method for identifying those most at risk of OP poisoning. The effect of the PON1 polymorphisms on activity may explain why some Gulf War veterans have developed Gulf War syndrome and some have not, despite similar OP exposure. 5. PON1 may also be a determinant of resistance to the development of atherosclerosis by protecting lipoproteins against oxidative modification, perhaps by hydrolyzing phospholipid hydroperoxides. 6. The PON 1 polymorphisms are important in determining the capacity of HDL to protect low density lipoprotein against oxidative modification in vitro, which may explain the relation between the PON1 alleles and coronary heart disease in case-control studies.
Similar articles
-
Low serum paraoxonase: a risk factor for atherosclerotic disease?Chem Biol Interact. 1999 May 14;119-120:389-97. doi: 10.1016/s0009-2797(99)00050-2. Chem Biol Interact. 1999. PMID: 10421475 Review.
-
Paraoxonase and coronary heart disease.Curr Opin Lipidol. 1998 Aug;9(4):319-24. doi: 10.1097/00041433-199808000-00006. Curr Opin Lipidol. 1998. PMID: 9739487 Review.
-
Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon.Br J Pharmacol. 1997 Sep;122(2):265-8. doi: 10.1038/sj.bjp.0701390. Br J Pharmacol. 1997. PMID: 9313934 Free PMC article.
-
Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates.J Toxicol Clin Toxicol. 2003;41(1):37-45. doi: 10.1081/clt-120018269. J Toxicol Clin Toxicol. 2003. PMID: 12645966 Review.
-
Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.FEBS Lett. 1998 Feb 13;423(1):57-60. doi: 10.1016/s0014-5793(98)00064-7. FEBS Lett. 1998. PMID: 9506841
Cited by
-
Phage display for identification of serum biomarkers of traumatic brain injury.J Neurosci Methods. 2016 Oct 15;272:33-37. doi: 10.1016/j.jneumeth.2016.04.026. Epub 2016 May 7. J Neurosci Methods. 2016. PMID: 27168498 Free PMC article.
-
Epimedium koreanum Extract and Its Flavonoids Reduced Atherosclerotic Risk via Suppressing Modification of Human HDL.Nutrients. 2019 May 18;11(5):1110. doi: 10.3390/nu11051110. Nutrients. 2019. PMID: 31109081 Free PMC article.
-
CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study.BMC Cancer. 2009 Apr 20;9:115. doi: 10.1186/1471-2407-9-115. BMC Cancer. 2009. PMID: 19379515 Free PMC article.
-
Lecithin-cholesterol acyltransferase and paraoxonase-1 levels in atherosclerotic cardiovascular disease patients in Nigeria.Afr J Lab Med. 2024 Jul 17;13(1):2286. doi: 10.4102/ajlm.v13i1.2286. eCollection 2024. Afr J Lab Med. 2024. PMID: 39114750 Free PMC article.
-
Paraoxonase/MCS.Environ Health Perspect. 1999 Aug;107(8):A395. doi: 10.1289/ehp.107-1566473. Environ Health Perspect. 1999. PMID: 10441320 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous